Search results
Building capacity for new modalities: Inside Cytiva’s first end-to-end cGMP facility for mRNA...
Pharmaceutical Technology· 1 day agomRNA vaccines are a key focus for the biopharma industry. Despite this, there has been a lack of...
Buy or build: Strategies to meet demand for vaccine and viral vector production
Pharmaceutical Technology· 1 day agoIn the mid-20th century, the successful development and large-scale production of vaccines for a...
Trends in biopharma: the future of manufacturing
Pharmaceutical Technology· 1 day agoAs innovative, novel biologics transform the biopharmaceutical market, improved processes and technological developments are likewise changing the future...
Strategies to address the viral vector manufacturing shortage
Pharmaceutical Technology· 1 day agoWith the exciting promise of addressing previously unmet medical needs, the rapidly growing field of...
Viral vector manufacturing: design considerations to improve commercial success
Pharmaceutical Technology· 1 day agoViral vector manufacturing: the key to the success of gene therapy Frost & Sullivan recently invited...
Best Steroids For Beginners - First Steroid Cycle For Muscle Growth And Cutting Cycles
Outlook India· 1 day agoWinstrol is a popular anabolic steroid that's a sterling choice for beginners embarking on their...
A standard approach to drug development for accessing the globe
Pharmaceutical Technology· 1 day agoStandardization in business requires us to take a step back from the belief that our technology and processes are unique and require specialized tools or environments. The revelation that significant ...
FDA shuns Rocket’s immune disorder gene therapy over manufacturing shortcomings
Pharmaceutical Technology· 1 day agoThe US Food and Drug Administration (FDA) has declined to approve Rocket Pharmaceutical’s Kresladi...
A growing scourge of rare genetic diseases and why it matters for India
Financial Express· 1 day agoA peep into the human genomic makeup is no more the preserve of the well-heeled. Today, thanks to...
23andMe and Nightingale partner to pilot blood-based risk detection panel
Medical Device Network· 1 day ago23andMe has partnered with Finland-based biomarker testing and risk prediction company Nightingale...